IntelGenx Announces Addition of Peterborough's Kawartha Centre as Montelukast VersaFilm® Phase 2a Clinical Trial Site

Stock Information for IntelGenx Technologies Corp.

Loading

Please wait while we load your information from QuoteMedia.